Galectin Therapeutics (GALT) Market Capitalization (2009 - 2026)
Galectin Therapeutics' Market Capitalization was $307.69 million in Q2 2026, up 127.6% from $135.17 million a year earlier and up 67.5% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Market Capitalization (2009 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Galectin Therapeutics came in at $271.24 million, up 232.9% from FY2024.
- Market Capitalization shows a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $81.47 million in FY2024 (-20.7%), $102.68 million in FY2023 (+52.9%), $67.15 million in FY2022 (-45.3%) and $122.84 million in FY2021 (-3.9%).
- The Q2 2026 figure marks the highest quarterly Market Capitalization since Q1 2014.
- Compared with a year earlier, Market Capitalization has increased for four straight quarters, with growth averaging 66.2% over the last eight quarters.
- The best year-over-year quarter for Market Capitalization over five years was Q4 2025 (growth of 232.9%); the worst was Q2 2022 (a decline of 59.0%).
- Per Business Quant data, GALT's Market Capitalization in the three quarters before Q2 2026 was $183.74 million (Q1 2026), $271.24 million (Q4 2025) and $273.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 307.69 Mn |
| Mar 31, 2026 | 183.74 Mn |
| Dec 31, 2025 | 271.24 Mn |
| Sep 30, 2025 | 273.36 Mn |
| Jun 30, 2025 | 135.17 Mn |
| Mar 31, 2025 | 77.22 Mn |
| Dec 31, 2024 | 81.47 Mn |
| Sep 30, 2024 | 171.35 Mn |
| Jun 30, 2024 | 140.75 Mn |
| Mar 31, 2024 | 148.53 Mn |
| Dec 31, 2023 | 102.68 Mn |
| Sep 30, 2023 | 118.75 Mn |
| Jun 30, 2023 | 85.80 Mn |
| Mar 31, 2023 | 125.12 Mn |
| Dec 31, 2022 | 67.15 Mn |
| Sep 30, 2022 | 96.86 Mn |
| Jun 30, 2022 | 77.81 Mn |
| Mar 31, 2022 | 95.62 Mn |
| Dec 31, 2021 | 122.84 Mn |
| Sep 30, 2021 | 230.24 Mn |
API Access
Galectin Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();